Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve i) to consider and take on record the audited standalone and consolidated financial results of the company for the quarter and year ended 31st March 2026, \r\n\r\nii) to recommend dividend, if any and\r\n\r\niii) to transact any other matter as may be specified in the agenda.\r\n